González-Galván MC, Mosqueda-Taylor A, Bologna-Molina R, Se-tien-Olarra A, Marichalar-Mendia X, Aguirre-Urizar JM. Evaluation of the osteoclastogenic process associated with RANK / RANK-L / OPG in odontogenic myxomas. Med Oral Patol Oral Cir Bucal. 2018 May 1;23 (3):e315-9.

doi:10.4317/medoral.22372

http://dx.doi.org/doi:10.4317/medoral.22372

1. Schmidt-Westhausen A, Becker J, Schuppan D, Burkhardt A, Reichart PA. Odontogenic myxoma--characterisation of the extracellular matrix (ECM) of the tumour stroma. Eur J Cancer B Oral Oncol. 1994;30B:377-80. https://doi.org/10.1016/0964-1955(94)90015-9

2. Mosqueda Taylor A, Ledesma Montes C, Caballero Sandoval S, Portilla Robertson J, Ruíz Godoy Rivera LM, Meneses García A. Odontogenic tumors in Mexico: a collaborative retrospective study of 349 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:672-5. https://doi.org/10.1016/S1079-2104(97)90371-1

3. Ochsenius G, Ortega A, Godoy L, Pe-afiel C, Escobar E. Odontogenic tumors in Chile: a study of 362 cases. J Oral Pathol Med. 2002;31:415-20. https://doi.org/10.1034/j.1600-0714.2002.00073.x PMid:12165060

4. Ladeinde AL, Ajayi OF, Ogunlewe MO, Adeyemo WL, Arotiba GT, Bamgbose BO, et al. Odontogenic tumors: a review of 319 cases in a Nigerian teaching hospital. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:191-5. https://doi.org/10.1016/j.tripleo.2004.08.031 PMid:15660091

5. Buchner A, Merrell PW, Carpenter WM. Relative frequency of central odontogenic tumors: a study of 1,088 cases from Northern California and comparison to studies from other parts of the world. J Oral Maxillofac Surg. 2006;64:1343-52. https://doi.org/10.1016/j.joms.2006.05.019 PMid:16916667

6. Jing W, Xuan M, Lin Y, Wu L, Liu L, Zheng X, et al. Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg. 2007;36:20-5. https://doi.org/10.1016/j.ijom.2006.10.011 PMid:17156974

7. Sriram G, Shetty RP. Odontogenic tumors: a study of 250 cases in an Indian teaching hospital. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:14-21. https://doi.org/10.1016/j.tripleo.2008.02.021 PMid:18417378

8. Luo HY, Li TJ. Odontogenic tumors: a study of 1309 cases in a Chinese population. Oral Oncol. 2009;45:706-11. https://doi.org/10.1016/j.oraloncology.2008.11.001 PMid:19147397

9. Gupta B, Ponniah I. The pattern of odontogenic tumors in a government teaching hospital in the southern Indian state of Tamil Nadu. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:32-9. https://doi.org/10.1016/j.tripleo.2010.02.035 PMid:20610293

10. Osterne RL, Brito RG, Alves AP, Cavalcante RB, Sousa FB. Odontogenic tumors: a 5-year retrospective study in a Brazilian population and analysis of 3406 cases reported in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:474-81. https://doi.org/10.1016/j.tripleo.2010.10.018 PMid:21239191

11. Siriwardena BS, Tennakoon TM, Tilakaratne WM. Relative frequency of odontogenic tumors in Sri Lanka: Analysis of 1677 cases. Pathol Res Pract. 2012;208:225-30. https://doi.org/10.1016/j.prp.2012.02.008 PMid:22439972

12. Da-Costa DO, Maurício AS, De Faria PA, Da Silva LE, Mosqueda Taylor A, Lourenço SD. Odontogenic tumors: a retrospective study of four Brazilian diagnostic pathology centers. Med Oral Patol Oral Cir Bucal. 2012;17:389-94. https://doi.org/10.4317/medoral.17630 PMCid:PMC3476089

13. Barker BF. Odontogenic myxoma. Semin Diagn Pathol. 1999;16:297-301. PMid:10587272

14. Martínez Mata G, Mosqueda Taylor A, Carlos Bregni R, De Almeida OP, Contreras Vidaurre E, Vargas PA, et al. Odontogenic myxoma: clinico-pathological, immunohistochemical and ultrastructural findings of a multicentric series. Oral Oncol. 2008;44:601-7. https://doi.org/10.1016/j.oraloncology.2007.08.009 PMid:17996487

15. Gomes CC, Diniz MG, Duarte AP, Bernardes VF, Gomez RS. Molecular review of odontogenic myxoma. Oral Oncol. 2011;47:325-8. https://doi.org/10.1016/j.oraloncology.2011.03.006 PMid:21444236

16. Simon EN, Merkx MA, Vuhahula E, Ngassapa D, Stoelinga PJ. Odontogenic myxoma: a clinicopathological study of 33 cases. Int J Oral Maxillofac Surg. 2004;33:333-7. https://doi.org/10.1016/j.ijom.2003.12.004 PMid:15145033

17. Tekkesin MS, Mutlu S, Olgac V. The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. Head Neck Pathol. 2011;5;248-53. https://doi.org/10.1007/s12105-011-0271-1 PMid:21643971 PMCid:PMC3173533

18. Wittrant Y, Théoleyre S, Chipoy C, Padrines M, Blanchard F, Heymann D, et al. RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta. 2004;1704:49-57. https://doi.org/10.1016/j.bbcan.2004.05.002

19. Da Silva TA, Batista AC, Mendonça EF, Leles CR, Fukada S, Cunha FQ. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:333-41. https://doi.org/10.1016/j.tripleo.2007.06.009 PMid:18061491

20. Tekkesın MS, Mutlu S, Olgaç V. Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic Odontogenic Tumor) in comparison with ameloblastomas and radicular cysts. Turk Patoloji Derg. 2012;28:49-55 https://doi.org/10.5146/tjpath.2012.01097

21. Seifert M, Nelke KH, Noczyńska A, Łysenko L, Kubacka M, Gerber H. Bone markers in craniofacial bone deformations and dysplasias. Postepy Hig Med Dosw. 2015;28;1176-81. https://doi.org/10.5604/17322693.1176768

22. Odell EW, Adebly K. Odontogenic myxoma /myxofibroma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. World Health Organization Classification of Head and Neck Tumours. Lyon: IARC Press; 2017. p.290.

23. Andrade FR, Sousa DP, Mendonça EF, Silva TA, Lara VS, Batista AC. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:548-55. https://doi.org/10.1016/j.tripleo.2008.05.042 PMid:18928898

24. Bologna Molina R, Damián Matsumura P, Molina Frechero N. An easy cell counting method for immunohistochemistry that does not use an image analysis program. Histopathology. 2011;59:801-3. https://doi.org/10.1111/j.1365-2559.2011.03954.x PMid:21939456

25. Wu PF, Tang JY, Li KH. RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects.Tumour Biol. 2015;36:495-501. https://doi.org/10.1007/s13277-015-3094-y PMid:25618600

26. Qian Y, Huang HZ. The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. J Oral Pathol Med. 2010;39:592-8. https://doi.org/10.1111/j.1600-0714.2009.00882.x PMid:20412401

27. De Matos FR, De Moraes M, Das Neves Silva EB, Galvão HC, De Almeida Freitas R. Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors.. J Oral Maxillofac Surg. 2013;71:1886-92. https://doi.org/10.1016/j.joms.2013.05.023 PMid:23992784

28. Bologna-Molina R, Mosqueda-Taylor A, Domínguez-Malagón H, Salazar-Rodríguez S, Tapia G, Gónzalez-Gónzalez R et al. Immunolocalization of VEGF-A and orosomucoid-1 in odontogenic myxoma Rom J Morphol Embryol. 2015;56:465-473. PMid:26193215

29. González-Galván MC, Aguirre-Urizar JM, Bologna-Molina R, Farfán-Morales JE, Gainza-Cirauqui ML, Marichalar-Mendia X et al. Assessment of CD-105 as an Angiogenic Modulator in Odontogenic Myxomas and Dental Follicles. Int J Surg Pathol. 2016;24:315-9. https://doi.org/10.1177/1066896916632588 PMid:26888956